medigraphic.com
Colegio de Medicina Interna de México.

2010, Number 6

<< Back Next >>

Med Int Mex 2010; 26 (6)

Marchiafava-Bignami disease in two Mexican patients. Pathologic findings and clinical and radiological correlation

Reyes SG, Castillo RC, Cabrera RA

Language: Spanish
References: 31
Page: 619-624
PDF size: 497.54 Kb.


ABSTRACT

The Marchiafava-Bignami disease was described by Marchiafava and Bignami in two alcoholics Italians patients, they presented seizures, coma and death. The clinical characteristics are varied, but the most common are dementia, impaired attention, difficulty in gait and interhemisférica disconnection, this syndrome are caused by demyelination of the corpus callosum. We reported the clinical, radiologic and histologic features using tissue obtained by stereotaxy biopsy and craniotomy. Two patients were described with history of chronic alcoholism. The differential diagnosis of the lesions in the corpus callosum must include EMB, acute disseminated encephalomyelitis, lymphoma, multiform glioblastoma and infectious lesions. These are the firsts mexican cases reports with EMB, documented by clinical radiological and histopathologically.


REFERENCES

  2. Marchiafava E, Bignami A. Sopra un alterazione del corpo calloso osservata in soggetti alcoolisti. Riv Patol Nerv 1903; 8:544-547.

  3. Kosaka K, Aoki M, Kawasaki N, Adachi Y, Konuma I, Iizuka R. A non-alcoholic japanese patient with Wernicke’s encephalopathy and Marchiafava-Bignami disease. Clin Neuropathol 1984; 3:231-6.

  4. Leong AS. Marchiafava-Bignami disease in a non-alcoholic indian male. Pathology. 1979; 11:241-9.

  5. Canaple S, Rosa A, Mizon JP Marchiafava-Bignami disease. Interhemispheric disconnection, favourable outcome, neurological aspect. Rev Neurol 1992; 148:638–640.

  6. Kohler CG, Ances BM, Coleman AR, Ragland JD, Lazarev M,Gur RC Marchiafava-Bignami disease: literature review and case report. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13:67–76.

  7. Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J Neurol 2004; 251:1050-9.

  8. Friese SA, Bitzer M, Freudenstein D. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000; 42:795–802.

  9. Kuhlmann T, Schröter A, Dechent P. Diagnosis of multifocal B cell lymphoma with preceding demyelinating CNS lesions by single-voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 2001; 70:259–262.

  10. Navarro JF, Noriega S. Enfermedad de Marchiafava-Bignami. Rev-Neurol. 1999; 28:519-23.

  11. Kosaka K, Aoki M, Kawasaki N. A non-alcoholic Japanese patient with Wernicke’s encephalopathy and Marchiafava- Bignami disease. Clin Neuropathol 1984; 3:1-236.

  12. Leong ASY. Marchiafava-Bignami disease in a non-alcoholic Indian male. Pathology 1979; 11:241-249.

  13. Marjama J, Yoshino MT, Reese Ch. MarchiafavaBignami disease: premorten diagnosis of an acute case utilizing magnetic resonance imaging. J Neuroimaging 1994;4:1069.

  14. Heepe P, Nemeth L, Brune F, et al. MarchiafavaBignami disease: a correlative computed tomography and morphological study. Eur Arch Psychiatry Neurol Sci 1988;237:749.

  15. Kawamura M, Shiota J, Yagishita T, Hirayama K. Marchiafava-Bignami disease: computed tomographic scan and magnetic resonance imaging. Ann Neurol 1985;18:1034.

  16. Yahya C, Meryem Kaya , Semra S. Marchiafava-Bignami disease: cranial MRI and SPECT findings. Clinical Neurology and Neurosurgery 2002; 104:339-341.

  17. Chang KH, Cha SH, Han MH. Marchiafava-Bignami disease: serial changes in corpus callosum on MRI. Neuroradiology 1992;34:480-482.

  18. Haris I. Sair, Feroze B. Mohamed, Sunil Patel. Diffusion Tensor Imaging and Fiber-Tracking in Marchiafava-Bignami Disease. Journal of Neuroimaging 2006; 16:281-285.

  19. Kamaki M, Kawamura M, Moriya H, Hirayama K. Callosal bleeding in a case of MarchiafavaBignami disease. J Neurol Sci 1996;136:869-872.

  20. Ruiz-Martinez J, Martinez Perez-Balsa A, Ruibal M, et al. Marchiafava- Bignami disease with widespread extracallosal lesions and favourable course. Neuroradiology 1999; 41:40-43.

  21. Shiota J, Nakano I, Kawamura M, Hirayama K. An autopsy case of MarchiafavaBignami disease with peculiar chronological CT changes in the corpus callosum: neuroradiopathological correlations. J Neurol Sci 1996; 136:903-905.

  22. Kuhlmann T, Lassmann H, Brück W. Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol 2008; 115:275-287.

  23. Mix E, Olsson T, Correale J, Baig S, Kostulas V, Olsson O, Link H: B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 1990; 79:21-27.

  24. Kevin C. O’connor. The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in Immunopathogenesis. J Clin Immunol 2001; 21:81-93.

  25. Correale J, Mix E, Olsson T, Kostulas V, Fredrikson S, Hojeberg B, Link H: CD51 B cells and CD4-82 T cells in neuroimmunological diseases. J Neuroimmunol 1991; 32:123-132.

  26. Antonio Iglesias, Jan Bauer. T-and b-cell responses to myelin Oligodendrocyte glycoprotein in Experimental autoimmune Encephalomyelitis and Multiple sclerosis. Glia 2001; 36:220-234.

  27. Annegrit Gerlach, Eckard Oehm, Jens Wattchow. Use of highdose cortisone in a patient with Marchiafava- Bignami disease. J Neurol 2003;250:758-760.

  28. Jun Fukumoto, Takeo Suzuki. Marchiafava-Bignami disease treated by mianserin hydrochloride in short-term evaluated by neuropsychological analysis. Psychogeriatrics 2007;7:25-32.

  29. Falangola MF, De Queiroz A. Necrose primaria do corpo caloso (Doença de Marchiafava-Bignami). Arq Neuropsiquiatr 1992;50:507-12.

  30. Delangre T, Hannequin D, Clavier E, Denis P, Mihout B, Samson M. Maladie de Marchiafava-Bignami d’evolution favorable. Rev Neurol 1986;142:933-936.

  31. Martínez Fernández R, Manzano L, Cabrera F, Arranz A. Enfermedad de Marchiafava-Bignami de evolución clínica favorable. Rev Clin Esp 1992; 190:431-443.




2020     |     www.medigraphic.com